Melbourne, Vic, December 12th, 2018 – Kensana Health announced today that Founder and Chairman Ken Clement has joined the board of directors at Syqe Medical in Israel.
In 2014, CEO of Syqe Medical Perry Davidson first met with Ken Clement in Tel Aviv. He learned about Ken’s pursuit to grow plants with consistent active compounds batch after batch, within a deviation of less than 10%. As the Syqe inhaler requires a standardized compound to achieve pharmaceutical level regulatory approval, Perry was interested in visiting Ken’s Canadian production facility to personally inspect the growing methods. This visit, along with Syqe’s reception of a white paper written by the University of Guelph that verified the production facility’s successful standardized growing methods, marked the beginning of their partnership.